Keyphrases
Dementia Risk
100%
Type 2 Diabetic Patients
100%
Nested Case-control Study
100%
Dementia
100%
Antidiabetic Drugs
100%
Confidence Interval
80%
Dipeptidyl peptidase-4 (DPP-4)
60%
Metformin
60%
Glucagon-like peptide-1 (GLP-1)
60%
Medication Use
40%
Odds Ratio
40%
Defined Daily Dose
40%
Dementia with
20%
Diabetes
20%
Conditional Logistic Regression
20%
Risk Factors for Dementia
20%
Risk-set Sampling
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Follow-up Time
20%
Synergistic Effect
20%
Combined Treatment
20%
Ever Use
20%
Sulfonylurea
20%
Treatment Regime
20%
Acarbose
20%
Diabetes Registry
20%
Logistic Regression Model
20%
Low Risk
20%
Potential Confounders
20%
Anti-dementia Drugs
20%
Dementia Diagnosis
20%
Insulin
20%
Glitazones
20%
Patients with Diabetes
20%
Medicine and Dentistry
Case-Control Study
100%
Dipeptidyl Peptidase-4 Inhibitor
100%
Patient with Type 2 Diabetes
100%
Sodium Glucose Cotransporter
100%
Glycon
100%
Odds Ratio
66%
Diabetes
66%
Maturity Onset Diabetes of the Young
33%
Sulfonylurea
33%
Logistic Regression Analysis
33%
Patient with Diabetes
33%
Acarbose
33%
Pharmacology, Toxicology and Pharmaceutical Science
Case-Control Study
100%
Dipeptidyl Peptidase IV Inhibitor
100%
Metformin
100%
Non Insulin Dependent Diabetes Mellitus
100%
Sodium Glucose Cotransporter
100%
Defined Daily Dose
66%
Sulfonylurea
33%
Acarbose
33%
Neuroscience
Sodium Glucose Cotransporter
100%
Acarbose
33%